RaQualia Pharma seeks to create value-added, innovative new drugs that truly contribute to society by building a large, open collaborative network with universities, public research institutions, pharmaceutical companies and venture businesses.

In order to create one new drug, an enormous amount of research funding together with the latest science, technology and know-how are essential. RaQualia is home to researchers who have specialized knowledge that is the key to achieving this objective. We put into practice our own business model, the "Integrated Open Collaboration Network Model," so that we can bring forth valuable medicines that will contribute tangibly to society.

We are confident that by doing so we can evolve our business in a way that will be useful to everyone.

We actively seek to license-out our portfolio. If your company is planning to expand its pipeline, you may consider using our portfolio. We offer innovative proposals that will lead your business to success.

We also strive to enhance our portfolio. In particular, we plan to enter into license agreements needed to expand our business in the areas of pain and gastrointestinal disease.